Parkinson Hastalığı ve Depresyonu Olan Hastalarda Monoamin Kaybı ve Fonksiyonel Bağlanma Değişimleri.
Monoamine Loss and Functional Connectivity Alterations in Patients With Parkinson's Disease and Depression.
DOI: 10.1002/cns.70705PMID: 41450012
Monoamine Loss and Functional Connectivity Alterations in Patients With Parkinson's Disease and Depression.
DOI: 10.1002/cns.70705PMID: 41450012
Motor response in monogenic LRRK2 parkinson's disease after deep brain stimulation: A systematic review and meta-analysis.
PMID: 41451724
Neuroprotective Effects of PEP-1-PGAM5 via the Attenuation of Oxidative Stress and Apoptosis in Parkinson's Disease.
DOI: 10.1111/jnc.70324PMID: 41452269
Association of triglyceride glucose-waist to height ratio index with Parkinson's disease and the mediating role of systemic inflammatory response index: A cross-sectional study.
DOI: 10.1097/md.0000000000046737PMID: 41465946
Exercise with induced pluripotent stem cells enhances Wnt1-Lmx1a signaling and dopaminergic neurogenesis to alleviate Parkinsonian symptoms.
DOI: 10.4252/wjsc.v17.i12.113924PMID: 41480396
Targeting the <i>LRRK2 G2019S</i> Mutation Found in Parkinson's Disease: Efficiency of Biosynthesized Solid Lipid Nanoparticles for Therapeutic siRNA-Mediated Gene Therapy.
DOI: 10.31083/fbe44344PMID: 41504091
Life's Essential 8 and Parkinson's Disease Risk: A Cross-Sectional Study Based on NHANES Data (2005-2018).
DOI: 10.31083/rn38937PMID: 41504198
Gut-Brain Axis: The Role of Gastrointestinal Issues in Parkinson's Disease.
PMID: 41586427
[Motor and non-motor symptoms of Parkinson's disease in the elderly population].
DOI: 10.1684/pnv.2025.1253PMID: 41627009
Butyrate-Modified Hyaluronic Acid Ameliorates MPTP-Induced Parkinson's Disease via Modulating PINK1/Parkin-Involved Mitophagy and Intestinal Flora.
DOI: 10.1021/acs.biomac.5c00967PMID: 41324423
High fear-of-falling in Parkinson's disease: Distinct clinical phenotypes with motor and non-motor dominance.
DOI: 10.1016/j.parkreldis.2025.108138PMID: 41330134
Association between cognitive adverse effects of anticholinergic medication and development of dementia in Parkinson's disease.
DOI: 10.1016/j.parkreldis.2025.108136PMID: 41349504
Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.